-
Neuropsychiatric evaluation in patients with functionel movements disorders
-
Neuropsychiatric Issues in Parkinson’s Disease
-
Neutralizing Antibody Conversion With OnabotulinumtoxinA From Global Studies Across Multiple Indications With A Focus On Movement Disorders: A Meta-Analysis
-
New insight into REM-sleep atonia circuits underlying REM sleep behavior disorder in living humans
-
New presenilin-1 missense variant (p.Pro88Arg) characterized by initial progressive supranuclear palsy like phenotype.
-
New-onset movement disorders in patients with COVID-19 from two centers in Western India
-
Next-generation sequencing of plasma-associated extracellular vesicle miRNAs as potential biomarkers for Parkinson’s disease and its prodromal stage
-
Night Vision Blindness Should Be Discussed with our Parkinson’s Disease Patients – sooner rather than later.
-
NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson’s Disease
-
Non-invasive imaging markers of iron accumulation in Multiple System Atrophy
- « Previous Page
- 1
- …
- 80
- 81
- 82
- 83
- 84
- …
- 132
- Next Page »